ZIM LABORATORIES
Quarterly Results Analysis [Mar2025]
ZIM LABORATORIES Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 Audited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹109 Cr | ₹96 Cr | ₹92 Cr | ₹82 Cr | ₹118 Cr | ₹96 Cr | ₹86 Cr | ₹67 Cr |
Expenses | ₹94 Cr | ₹85 Cr | ₹83 Cr | ₹74 Cr | ₹102 Cr | ₹85 Cr | ₹77 Cr | ₹63 Cr |
Operating Income | ₹15 Cr | ₹12 Cr | ₹10 Cr | ₹8 Cr | ₹16 Cr | ₹12 Cr | ₹9 Cr | ₹5 Cr |
Other Income | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Interest | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr |
Depreciation | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
Profit Before Tax | ₹8 Cr | ₹6 Cr | ₹3 Cr | ₹1 Cr | ₹11 Cr | ₹7 Cr | ₹5 Cr | ₹0 Cr |
Profit After Tax | ₹5 Cr | ₹4 Cr | ₹2 Cr | ₹1 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹0 Cr |
EPS | ₹1.00 | ₹0.82 | ₹0.49 | ₹0.18 | ₹1.66 | ₹0.98 | ₹0.85 | ₹0.05 |
Industry Peers & Returns | 1W | 1M | 1Y |
ZIM LABORATORIES | 13.8% | 22.9% | 5.5% |
SUN PHARMACEUTICAL INDUSTRIES | 1.6% | -2.9% | 17.2% |
DIVIS LABORATORIES | 1.5% | 10.4% | 51.9% |
CIPLA | 2.3% | 1.9% | 2.8% |
TORRENT PHARMACEUTICALS | 1.4% | 1.3% | 17% |
DR REDDYS LABORATORIES | 5.7% | 14.1% | 15.2% |
MANKIND PHARMA | 0.2% | -2.4% | 12.5% |
ZYDUS LIFESCIENCES | 5.1% | 10.9% | -4.4% |
LUPIN | 2% | -2.2% | 27.9% |
ZIM LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 12.88 % |
Y-o-Y | -7.75 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹109 Cr | 12.88 | |
Dec2024 | ₹96 Cr | 4.54 | |
Sep2024 | ₹92 Cr | 12.61 | |
Jun2024 | ₹82 Cr | -30.58 | |
Mar2024 | ₹118 Cr | 22.40 | |
Dec2023 | ₹96 Cr | 12.20 | |
Sep2023 | ₹86 Cr | 27.26 | |
Jun2023 | ₹67 Cr | - |
ZIM LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 26.23 % |
Y-o-Y | -6.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹15 Cr | 26.23 | |
Dec2024 | ₹12 Cr | 21.32 | |
Sep2024 | ₹10 Cr | 18.59 | |
Jun2024 | ₹8 Cr | -48.64 | |
Mar2024 | ₹16 Cr | 35.67 | |
Dec2023 | ₹12 Cr | 23.70 | |
Sep2023 | ₹9 Cr | 93.04 | |
Jun2023 | ₹5 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.83 % |
Y-o-Y | 1.05 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 13.42% | 11.83 | |
Dec2024 | 12% | 16.05 | |
Sep2024 | 10.34% | 5.30 | |
Jun2024 | 9.82% | -26.05 | |
Mar2024 | 13.28% | 10.85 | |
Dec2023 | 11.98% | 10.31 | |
Sep2023 | 10.86% | 51.68 | |
Jun2023 | 7.16% | - |
ZIM LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 22.07 % |
Y-o-Y | -39.61 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹5 Cr | 22.07 | |
Dec2024 | ₹4 Cr | 68.04 | |
Sep2024 | ₹2 Cr | 165.14 | |
Jun2024 | ₹1 Cr | -88.90 | |
Mar2024 | ₹8 Cr | 68.97 | |
Dec2023 | ₹5 Cr | 15.35 | |
Sep2023 | ₹4 Cr | 1,735.84 | |
Jun2023 | ₹0 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 8.19 % |
Y-o-Y | -34.55 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 4.49 % | 8.19 | |
Dec2024 | 4.15 % | 60.85 | |
Sep2024 | 2.58 % | 134.55 | |
Jun2024 | 1.1 % | -83.97 | |
Mar2024 | 6.86 % | 38.03 | |
Dec2023 | 4.97 % | 2.90 | |
Sep2023 | 4.83 % | 1,320.59 | |
Jun2023 | 0.34 % | - |
ZIM LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 21.95 % |
Y-o-Y | -39.76 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹1 | 21.95 | |
Dec2024 | ₹0.82 | 67.35 | |
Sep2024 | ₹0.49 | 172.22 | |
Jun2024 | ₹0.18 | -89.16 | |
Mar2024 | ₹1.66 | 69.39 | |
Dec2023 | ₹0.98 | 15.29 | |
Sep2023 | ₹0.85 | 1,600.00 | |
Jun2023 | ₹0.05 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD